Results 21 to 30 of about 73,601 (288)
Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus [PDF]
, 2017 Patients with diabetes, especially pediatric ones, sometimes use continuous glucose monitoring (CGM) sensor in different positions from the approved ones. Here we compare the accuracy of Dexcom\uae G5 CGM sensor in three different sites: abdomen, gluteus
Claudio Cobelli +10 more
core +2 more sources
Diabetes, 2012 The discovery of insulin was lifesaving. However, it converted type 1 diabetes, which had been an acute and lethal disease, into a chronic disease, with its attendant complications. It had long been considered—and was clearly demonstrated in the Diabetes Control and Complications Trial (1)—that microvascular complications such as retinopathy ...
openaire +2 more sources
A case study in open source innovation: developing the Tidepool Platform for interoperability in type 1 diabetes management. [PDF]
, 2015 OBJECTIVE:Develop a device-agnostic cloud platform to host diabetes device data and catalyze an ecosystem of software innovation for type 1 diabetes (T1D) management.
Adi, Saleh +8 more
core +1 more source
Artificial Pancreas: Past, Present, Future [PDF]
Diabetes, 2011 The artificial pancreas (AP), known as closed-loop control of blood glucose in diabetes, is a system combining a glucose sensor, a control algorithm, and an insulin infusion device. AP developments can be traced back 50 years to when the possibility for external blood glucose regulation was established by studies in individuals with type 1 diabetes ...
COBELLI, CLAUDIO, Renard E, Kovatchev B.
openaire +2 more sources
JA Clinical Reports, 2019 Background Non-islet cell tumor producing insulin-like growth factor 2 involves hypoglycemia. During tumor resection, intense fluctuation of blood glucose level may occur. An artificial endocrine pancreas has been reported as beneficial for patients with
Kenzaburou Sugimoto +3 more
doaj +1 more source
The Lancet: Digital Health, 2021 Summary: Background: For people with type 1 diabetes, there is currently no automated insulin delivery system that does not require meal input. We aimed to assess the efficacy of a novel faster-acting insulin aspart (Fiasp) plus pramlintide fully closed-
Michael A Tsoukas, MD +8 more
doaj +1 more source
A linear control of composite model for glucose insulin glucagon pump
Ain Shams Engineering Journal, 2019 Presently Type 1 diabetes is global issue and challenges for diabetes public for healthy life. Fully automatic artificial pancreas is well solution for diabetic patients to avoid the hyperglycemia/hypoglycemia as it provided the insulin/glucose when ...
Muhammad Farman +4 more
doaj +1 more source
Symposium 4: Insuline pumps in artificial páncreas systems
Revista de la Sociedad Argentina de Diabetes, 2020 Symposium 4: Biology and technology in the treatment of diabetes Insuline pumps in artificial páncreas systems By year 2021, insuline discover will reach a centenary.
Adrián Proietti
doaj +1 more source
Characterization of Cyclic Olefin Copolymers for Insulin Reservoir in an Artificial Pancreas
Journal of Functional Biomaterials, 2023 Type-1 diabetes is one of the most prevalent metabolic disorders worldwide. It results in a significant lack of insulin production by the pancreas and the ensuing hyperglycemia, which needs to be regulated through a tailored administration of insulin ...
Norma Mallegni +7 more
doaj +1 more source
Personalized rule-based closed-loop control algorithm for type 1 diabetes [PDF]
, 2014 Type 1 diabetes-mellitus implies a life-threatening absolute insulin deficiency. Artificial pancreas (CGM sensor, insulin pump and control algorithm) is promising to outperform current open-loop ...
García García, Fernando +5 more
core +1 more source